Registry of Coronary Artery Ill Patients With Platelet Test Results (ONASSIST)

A

Action, France

Status

Enrolling

Conditions

Percutaneous Coronary Intervention
Acute Coronary Syndrome
Myocardial Infarction

Study type

Observational

Funder types

Other

Identifiers

NCT02762162
ONASSIST

Details and patient eligibility

About

ONASSIST is a registry of coronary ill patients who have had a functional test measuring anti-platelet effect and/or a genetic profile of response to anti-platelet drugs.

Full description

The Onassist Project is an assistance for cardiologists that establishes an individual risk of stent thrombosis for each patient based on: a functional approach (evaluation of the antiplatelet effect of the antiplatelet regimen by multiple tests) and a pharmacogenomic approach (genetic profile of response to antiplatelet agents) It provides advices for specific therapeutics after identification of adverse drug interactions, treatment compliance issues and true genetic, functional or mixed resistance. This individualized strategy allow to adjust the choice of the drugs and their optimal dosage considering the best benefit - risk ratio. Follow up are regularly made to identify markers of MACE (major adverse cardiac event) or bleeding.

Enrollment

5,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • coronary disease
  • antiplatelets testing performed as part of usual care and / or gentic profile of antiplatelet response done

Exclusion criteria

patient refusing to be part of the registry

Trial contacts and locations

1

Loading...

Central trial contact

Delphine Brugier, PhD; Jean Philippe COLLET, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems